CFA
AVNS

Carroll Financial Associates’s Avanos Medical AVNS Stock Holding History

Carroll Financial Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$8K Hold
242
– – ﹤0.01% 1210
2021
Q3 		$7K Sell
242
-91
-27% -$3.09K ﹤0.01% 1302
2021
Q2 		$12K Sell
333
-7
-2% -$289 ﹤0.01% 1225
2021
Q1 		$14K Buy
340
+7
+2% +$329 ﹤0.01% 1120
2020
Q4 		$15K Hold
333
– – ﹤0.01% 993
2020
Q3 		$11K Sell
333
-18
-5% -$575 ﹤0.01% 1001
2020
Q2 		$10K Hold
351
– – ﹤0.01% 1025
2020
Q1 		$9K Buy
351
+14
+4% +$418 ﹤0.01% 960
2019
Q4 		$11K Sell
337
-100
-23% -$3.62K ﹤0.01% 1014
2019
Q3 		$16K Buy
437
+200
+84% +$7.63K ﹤0.01% 877
2019
Q2 		$10K Hold
237
– – ﹤0.01% 1006
2019
Q1 		$10K Hold
237
– – ﹤0.01% 936
2018
Q4 		$9K Hold
237
– – ﹤0.01% 874
2018
Q3 		$16K Sell
237
-12
-5% -$772 ﹤0.01% 763
2018
Q2 		$14K Sell
249
-71
-22% -$3.75K ﹤0.01% 777
2018
Q1 		$14K Sell
320
-9
-3% -$427 ﹤0.01% 752
2017
Q4 		$15K Buy
329
+55
+20% +$2.53K ﹤0.01% 727
2017
Q3 		$12K Hold
274
– – ﹤0.01% 772
2017
Q2 		$10K Hold
274
– – ﹤0.01% 826
2017
Q1 		$10K Hold
274
– – ﹤0.01% 824
2016
Q4 		$10K Hold
274
– – ﹤0.01% 790
2016
Q3 		$9K Hold
274
– – ﹤0.01% 831
2016
Q2 		$8K Hold
274
– – ﹤0.01% 826
2016
Q1 		$7K Buy
274
+18
+7% +$480 ﹤0.01% 828
2015
Q4 		$8K Hold
256
– – ﹤0.01% 775
2015
Q3 		$7K Sell
256
-33
-11% -$1.15K ﹤0.01% 775
2015
Q2 		$12K Buy
289
+233
+416% +$10.5K ﹤0.01% 669
2015
Q1 		$3K Hold
56
– – ﹤0.01% 683
2014
Q4 		$2K Buy
+56
New +$2.2K ﹤0.01% 652

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Carroll Financial Associates's AVNS Position: Q4 2021 in Review

Carroll Financial Associates held its Avanos Medical (AVNS) position steady in Q4 2021 at 242 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1210.

Carroll Financial Associates first reported a position in AVNS in Q4 2014 and has held it in 29 quarters since. The position peaked at $16K in Q3 2019. 297 funds tracked by Wall St. Rank hold AVNS as of Q4 2021.

  • Carroll Financial Associates held 242 shares of Avanos Medical worth $8K as of Q4 2021.
  • Carroll Financial Associates left its Avanos Medical share count unchanged in Q4 2021.
  • Avanos Medical made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1210 holding.
  • Carroll Financial Associates first reported a position in Avanos Medical in Q4 2014 and has held it in 29 quarters since.
  • Carroll Financial Associates's Avanos Medical position peaked at $16K in Q3 2019.
  • 297 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.